PCM
GRCL

Prelude Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Prelude Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,974
Closed -$411K – 1467
2023
Q4 		$411K Buy
40,974
+24,647
+151% +$247K 0.03% 512
2023
Q3 		$47K Buy
+16,327
New +$47K ﹤0.01% 906